» Articles » PMID: 23940002

Analysis of MicroRNAs Expressions in Chondrosarcoma

Overview
Journal J Orthop Res
Publisher Wiley
Specialty Orthopedics
Date 2013 Aug 14
PMID 23940002
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are small non-coding RNAs capable of inhibiting gene expression post-transcriptionally and expression profiling can provide therapeutic targets and tools for cancer diagnosis. Chondrosarcoma is a mesenchymal tumor with unknown cause and differentiation status. Here, we profiled miRNA expression of chondrosarcoma, namely clinical samples from human conventional chondrosarcoma tissue, established chondrosarcoma cell lines, and primary non-tumorous adult articular chondrocytes, by miRNA array and quantitative real-time PCR. A wide variety of miRNAs were differently downregulated in chondrosarcoma compared to non-tumorous articular chondrocytes; 27 miRNAs: miR-10b, 23b, 24-1*, 27b, 100, 134, 136, 136*, 138, 181d, 186, 193b, 221*, 222, 335, 337-5p, 376a, 376a*, 376b, 376c, 377, 454, 495, 497, 505, 574-3p, and 660, were significantly downregulated in chondrosarcoma and only 2: miR-96 and 183, were upregulated. We further validated the expression levels of miRNAs by quantitative real-time PCR for miR-181a, let-7a, 100, 222, 136, 376a, and 335 in extended number of chondrosarcoma clinical samples. Among them, all except miR-181a were found to be significantly downregulated in chondrosarcoma derived samples. The findings provide potential diagnostic value and new molecular understanding of chondrosarcoma.

Citing Articles

MiR-6839-5p inhibits cell proliferation, migration and invasion; a possible correlation with the suppressing VEGFA expression in human chondrosarcoma cells.

Li F, Xu J, Zhu Y Discov Oncol. 2024; 15(1):175.

PMID: 38762695 PMC: 11102412. DOI: 10.1007/s12672-024-01038-5.


MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in Chondrosarcoma.

Skipar P, Dey M, Piatkowski J, Sulejczak D, Rutkowski P, Czarnecka A Int J Mol Sci. 2024; 25(6).

PMID: 38542153 PMC: 10970465. DOI: 10.3390/ijms25063176.


MiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells.

Veys C, Boulouard F, Benmoussa A, Jammes M, Brotin E, Redini F Front Oncol. 2023; 13:1220459.

PMID: 37719019 PMC: 10501397. DOI: 10.3389/fonc.2023.1220459.


Epigenetic Abnormalities in Chondrosarcoma.

Bereza M, Dembinski M, Zajac A, Piatkowski J, Dudzisz-Sledz M, Rutkowski P Int J Mol Sci. 2023; 24(5).

PMID: 36901967 PMC: 10003547. DOI: 10.3390/ijms24054539.


Association between microRNA 671 polymorphisms and the susceptibility to soft tissue sarcomas in a Chinese population.

Zhang P, Li X, Huang L, Hu F, Niu X, Sun Y Front Oncol. 2022; 12:960269.

PMID: 36016604 PMC: 9396023. DOI: 10.3389/fonc.2022.960269.


References
1.
Chang T, Mendell J . microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet. 2007; 8:215-39. DOI: 10.1146/annurev.genom.8.080706.092351. View

2.
Mayr C, Hemann M, Bartel D . Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science. 2007; 315(5818):1576-9. PMC: 2556962. DOI: 10.1126/science.1137999. View

3.
Zheng Y, Yin L, Chen H, Yang S, Pan C, Lu S . miR-376a suppresses proliferation and induces apoptosis in hepatocellular carcinoma. FEBS Lett. 2012; 586(16):2396-403. DOI: 10.1016/j.febslet.2012.05.054. View

4.
Hecht J, Hogue D, Strong L, Hansen M, Blanton S, Wagner M . Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8. Am J Hum Genet. 1995; 56(5):1125-31. PMC: 1801450. View

5.
Rozeman L, Szuhai K, Schrage Y, Rosenberg C, Tanke H, Taminiau A . Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations. Cancer. 2006; 107(2):380-8. DOI: 10.1002/cncr.22001. View